WISE develops a new generation of implantable leads for neuromonitoring and neuromodulation to treat chronic pain and Parkinson’s. The company’s electrodes are highly ergonomic, conformable, soft and thin, thus allowing great adhesion, minimal invasiveness and excellent adaptability on neural tissues, addressing major limitations of other existing technologies. They have the potential to improve the performance of neuromonitoring as well as treatment quality for patients who are already benefiting from neuromodulation.